Abstract | BACKGROUND: METHODS: RESULTS: CONCLUSION: Transdermal estrogen replacement therapy should be considered as a therapeutic support in order to contrast the elevated cardiovascular risk in postmenopausal women.
|
Authors | M G Modena, R Rossi, N Muia Jr, G Origliani, O Rombolà, R Molinari |
Journal | Giornale italiano di cardiologia
(G Ital Cardiol)
Vol. 28
Issue 6
Pg. 636-44
(Jun 1998)
ISSN: 0046-5968 [Print] Italy |
PMID | 9672776
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antihypertensive Agents
- Progesterone Congeners
- Estradiol
- Medroxyprogesterone Acetate
|
Topics |
- Antihypertensive Agents
(therapeutic use)
- Cardiovascular Diseases
(prevention & control)
- Drug Therapy, Combination
- Estradiol
(administration & dosage)
- Estrogen Replacement Therapy
(methods)
- Female
- Humans
- Hypertension
(blood, diagnosis, drug therapy)
- Medroxyprogesterone Acetate
(administration & dosage)
- Middle Aged
- Postmenopause
(blood, drug effects)
- Progesterone Congeners
(administration & dosage)
- Risk Factors
- Time Factors
|